The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Kyprolis (carfilzomib)
Australian Public Assessment Report
Device/Product Name
Kyprolis
Active ingredients
Carfilzomib
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-02664-1-6
Submission Type
Extension of indications
Decision
Approved